These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A review of low-dose ritonavir in protease inhibitor combination therapy. Cooper CL; van Heeswijk RP; Gallicano K; Cameron DW Clin Infect Dis; 2003 Jun; 36(12):1585-92. PubMed ID: 12802760 [TBL] [Abstract][Full Text] [Related]
3. Protease inhibitors: implications for HIV research and treatment. Churchill SA J Int Assoc Physicians AIDS Care; 1996 Jan; 2(1):13-8. PubMed ID: 11363325 [TBL] [Abstract][Full Text] [Related]
6. Freedom of choice. Vazquez E Posit Aware; 1996; 7(3):9, 19. PubMed ID: 11363432 [TBL] [Abstract][Full Text] [Related]
7. A patient's guide to protease inhibitors. Elperin A; Sax P AIDS Clin Care; 1996 Oct; 8(10):83-4. PubMed ID: 11363988 [TBL] [Abstract][Full Text] [Related]
8. Nelfinavir is number 4 -- but should it bat cleanup, or lead off? Mascolini M J Int Assoc Physicians AIDS Care; 1997 Jun; 3(6):17-21. PubMed ID: 11364427 [TBL] [Abstract][Full Text] [Related]
16. HIV monotherapy with ritonavir-boosted protease inhibitors: a systematic review. Bierman WF; van Agtmael MA; Nijhuis M; Danner SA; Boucher CA AIDS; 2009 Jan; 23(3):279-91. PubMed ID: 19114854 [TBL] [Abstract][Full Text] [Related]
17. Saquinavir plus ritonavir reduce viral load by 99.9 percent. Vazquez E Posit Aware; 1996; 7(6):8-9. PubMed ID: 11363983 [TBL] [Abstract][Full Text] [Related]
18. Disorders of lipid metabolism in patients with HIV disease treated with antiretroviral agents: frequency, relationship with administered drugs, and role of hypolipidaemic therapy with bezafibrate. Manfredi R; Chiodo F J Infect; 2001 Apr; 42(3):181-8. PubMed ID: 11545549 [TBL] [Abstract][Full Text] [Related]